Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04257409
Other study ID # 546417
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date January 1, 2019
Est. completion date January 1, 2021

Study information

Verified date February 2020
Source Charles University, Czech Republic
Contact Eliška Vrátná, Mgr.
Phone +420774549214
Email vratnae@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The recurrence of diabetic foot ulcers (DFU) is a key problem in podiatric care. It is very often given by biomechanical abnormalities frequently present in those patients. The aim of our randomized controlled study is to find possible changes as of plantar pressures as of biomechanics of the ankle and small joints in patients with type 2 diabetes mellitus with different degrees of neuropathy. During this project, investigators will examine the possible impact of 12-week lasting intervention program on the distribution of plantar pressures, joint mobility and muscle strength of lower limbs. The incidence of ulcerations / reulcerations and changes of psychosocial characteristics will be evaluated during the study period.

Approximately 60 patients with Type 2 diabetes mellitus will be included into the study. These patients will be randomized into 3 study groups - patients with type 2 DM with mild form of peripheral sensory neuropathy (20 subjects), patient with severe peripheral neuropathy (20 subjects) and those with diabetic foot syndrome, without active lesion (20 subjects). All patients will undergo 12 week lasting active intervention program consisting of recommendations by a physiotherapist focusing on the improvement of physical fitness, muscle strength and foot joint improvement. Control group will be consisted of 20 patients with healed diabetic foot.

The outcomes of this project will try to objectively verify in the randomized controlled trial the impact of exercise on lower limb biomechanics, mobility, self-sufficiency, quality of life in patients with type 2 diabetes mellitus at risk or already developed diabetic foot syndrome.


Recruitment information / eligibility

Status Recruiting
Enrollment 80
Est. completion date January 1, 2021
Est. primary completion date March 30, 2020
Accepts healthy volunteers No
Gender All
Age group 30 Years to 75 Years
Eligibility Inclusion Criteria:

- Type 2 diabetes mellitus

- sensoric neuropathy (mild - based on VPV 15-30 V or EMG results, severe - based on VPT above 50 V or EMG results)

- diabetic foot with healed diabetic foot ulcers, inactive Charcot foot

Exclusion Criteria:

- impossibility to exercise

- amaurosis

- non-compliance

- critical limb ischemia

- active ulcer, surgical wound

- active Charcot foot

- active carcinoma

- recent stroke (last 8 weeks)

- recent myocardial infarction (last 8 weeks)

- recent PTA, PCI, bypass (last 8 weeks)

- myopathy

- rheumatoid arthritis

- cox-, gonartrosis of 3rd -4th grade.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Physical intervention by exercise
12 week lasting exercise intervention

Locations

Country Name City State
Czechia Institute for Clinical and Experimental Medicine Prague

Sponsors (3)

Lead Sponsor Collaborator
Mgr. Eliška Vrátná prof. Ing. Václav Bunc, CSc, Vladimíra Fejfarová, MD, PhD

Country where clinical trial is conducted

Czechia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Biomechanics- plantar pressures plantar pressures will be evaluated by pedobarograph (in Newtons) changes after 12 weeks, 24 weeks
Primary Biomechanics- biomechanics of the ankle biomechanics of the ankle will be assessed by goniometry in angles changes after 12 weeks, 24 weeks
Primary Biomechanics- changes of foot joint angles changes of foot joint agles will be evaluated by measurement of X-Rays bones angles - calcaneal pitch, talar-1st metatarsal angle and lateral Talocalcaneal angle changes after 12 weeks, 24 weeks
Primary Fitness - physical activity The amount of physical activity will be assessed by IPAQ questioners changes after 12 weeks, 24 weeks
Primary Fitness - muscle strength Muscle strength will be measured by dynamometry in Newtons changes after 12 weeks, 24 weeks
Primary Fitness - senior fitness fitness will be assessed by seniorfittest containing 2 minutes step test (steps/2 min) and test of sitting (sits/30 seconds) changes after 12 weeks, 24 weeks
Secondary ulceration/reulceration detection of the incidence of ulceration/reulceration changes after 12 weeks, 24 weeks
Secondary Psychosocial changes - quality of life Quality of life will be evaluated by WHO-QoL Bref test (4 domains - high values mean bettr findings changes after 12 weeks, 24 weeks
Secondary Psychosocial changes - depression Depression status will be asessed by Geriatric Depression Scale (GDS) scale - minimum 0, maximum 30 points (higher then 9 points- mild form of depression, higher then 20 - severe depression changes after 12 weeks, 24 weeks
Secondary Psychosocial changes - stress readaptation Adaptation to stress will be detected by Stress Readaption Scale (0-400 points) - points higher then 150 - higher risk of worse stress readaptation and therefore higher risk of somatisation changes after 12 weeks, 24 weeks
Secondary Metabolism - glucose control Investigators will be loked for metabolic changes in diabetes control (HbA1c in mmol/mol, glycemia in mmol/l) changes after 12 weeks, 24 weeks
Secondary Metabolism - lipid profile The authors will control lipid profiles (Total-, HDL-, LDL-cholesterol in umol/l) changes after 12 weeks, 24 weeks
Secondary Metabolism - myokines Patients will be checked for changes in selected cytokines nad myokines (IL-4,6,7,8,15 in pg/ml, myostatin in pg/ml, irisin in ng/ml, FGF-21 in pg/ml) changes after 12 weeks, 24 weeks